Refine by
Injectable Biologic Equipment & Supplies
6 equipment items found
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
This device is supported by an ongoing NIH grant and potential for follow-on ...
Manufactured by:SHL Medical AG based inZug, SWITZERLAND
The first DAI was built for a multinational biopharmaceutical company headquartered in the US. It is a button-activated, 3-step disposable device for 1 mL pre-filled syringes. We were tasked to design an injection device that could facilitate an easier subcutaneous self-injection experience compared to the alternative pre-filled syringe or vial. For this reason, ...
Manufactured by:Brevetti Angela S.r.l. based inArzignano, ITALY
The SYFPAC SECUREJECT system is employed for the production of prefilled syringes and injection devices using Blow-Fill-Seal (BFS) technology. Ideal for mass production, it can produce syringes ranging from 0.5ml to 20ml sizes swiftly, forming, filling, and sealing each unit under aseptic conditions in just 16 seconds. The versatile machinery handles different polymers such as ...
Manufactured by:Vascugen Inc. based inMadison, WISCONSIN (USA)
Development of complex iPSC-based therapeutics benefits from an engineering mindset. Each layer of the development and manufacturing process is considered part of the ‘Full Stack’ that leads to finished product. An integrated stepwise approach improves the probability of arriving at the right therapeutic candidate and reduces downstream risks to manufacturing and delivery to the ...
Manufactured by:Biolot Medical based inYenimahalle/ANKARA, TURKEY
So-Visc is an introarticular injection produced by biological fermantation method and including ‘hyalunorik acid’ that is in high-purity and is generally used in the treatment of Osteoartirid. The product that is similar to joint-fluids found naturally in joints serves as lubricants and shock-absorber like joint-fluids. Namely, So-Visc is a ...
Manufactured by:Intersect ENT, Inc. based inMenlo Park, CALIFORNIA (USA)
SINUVA is the first and only FDA-approved stent for the treatment of nasal polyps in adult patients 18 years or older who have had ethmoid sinus surgery Are you still living with nasal polyps? Consider an alternative to another sinus surgery — SINUVA is a nonsurgical treatment option that can be placed in office. SINUVA delivers anti-inflammatory medicine directly to the nasal polyps, ...